Monday, June 24, 2013

Infusion Therapy Provider Capitalizes on Growing Market

MSD sees brighter future with MTR acquisition
© Kulty Stock Free Images
Medical Specialties Distributors (MSD), supplier of infusion therapy products and supplies sees a bright future.  With the infusion therapy industry predicted to grow 50% by 2019*, MSD strengthened its position with the recent acquisition of Medical Technology Resources (MTR).  MTR specializes in drug-delivery technology and the billing of infusion products to healthcare providers.   
 "MTR's unique offerings and strong presence in the Midwest enhances our leadership position in the growing home infusion and oncology markets," said James Beck, president and CEO, MSD.  "Over the past three years, we have grown our national footprint through partnerships with multi-site health care providers and strategic relationships with leading manufacturers.  This acquisition is one more step toward our goal of creating a stronger growth platform for MSD.
In 2010, MSD partnered with Water Street Healthcare Partners, a private equity firm that focuses exclusively on the healthcare market.
The U.S. market for infusion therapy devices was valued at just under $1.5 billion in 2012, a 3.2% increase over 2011*. The market includes infusion pumps, intravenous (IV) sets, and needleless connectors (NLCs).  Spurring growth is NLCs and disposable ambulatory infusion pumps (as the number of alternate infusion therapy sites increase).  >>Read more 
* RnR Market Research

No comments: